Evidence map›Paper›PMID 42172496›Full record

ArticleJournal of gynecologic oncology2026

Equitable authorship in Global Gynecologic Oncology trials: the Asia Pacific Gynecologic Oncology Trials Group (APGOT) framework.

Jae-Weon Kim, Alison Evans, David Tan, Jung-Bok Lee, Jung-Yun Lee, Yoland Antill, Kosei Hasegawa, APGOT Investigators

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of gynecologic oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jae-Weon KimDepartment of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea. kjwksh@snu.ac.kr.ORCID https://orcid.org/0000-0003-1835-9436
Alison EvansAustralia New Zealand Gynaecological Oncology Group, Sydney, Australia.ORCID https://orcid.org/0000-0002-9469-6111
David TanDepartment of Haematology-Oncology, National University Cancer Institute Singapore, Singapore.ORCID https://orcid.org/0000-0001-9087-5262
Jung-Bok LeeDivision of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-1420-9484
Jung-Yun LeeDepartment of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-7948-1350
Yoland AntillFaculty of Medicine and Health Sciences, Monash University, Melbourne, Australia.ORCID https://orcid.org/0000-0002-6366-5523
Kosei HasegawaDepartment of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka, Japan.ORCID https://orcid.org/0000-0002-1903-7001
APGOT Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42172496
PMCPMC13226097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.